AI assistant
Sending…
Syndax Pharmaceuticals Inc — Director's Dealing 2021
Sep 17, 2021
31977_dirs_2021-09-17_bf9b4465-1fbe-4931-a0a0-78c964512063.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Syndax Pharmaceuticals Inc (SNDX)
CIK: 0001395937
Period of Report: 2021-09-15
Reporting Person: Huber Martin H. Jr. (N/A)
More from Syndax Pharmaceuticals Inc
Proxy Solicitation & Information Statement
2026
Jun 4
Capital/Financing Update
2026
Jun 4
Annual Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6